Series A funding round for Escient Pharmaceuticals raising $40M in May 2018
Series A funding round for Escient Pharmaceuticals raising $40M in May 2018
| Investor | Firm Type | Partner |
|---|
5AM VenturesLEAD | Venture Capital | — |
The Column GroupLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Corporate Venture Capital | — | |
| Venture Capital | — | |
| Angel | Robert Garland | |
| Angel | Carol Gallagher |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$238M
Top Valuation
-
Escient Pharmaceuticals raised $40M in a Series A round.
The round was announced on 05/01/18.
The round was led by 5AM Ventures, The Column Group.